TIMP1 and diffuse large B-cell lymphoma: Moreover, TIMP-1 can complement the IPI score classification system (Fig. 8), improving the accuracy of prediction of relapsed and deceased DLBCL patients compared to using the IPI score alone (Fig. 8, D–F).